Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Global Payments Continues Card Processing for Wells Fargo

Published 09/02/2020, 01:45 AM
Updated 07/09/2023, 06:31 AM

Global Payments (NYSE:GPN) Inc.’s GPN unit Total System Services (NYSE:TSS) (TSYS), which is its Issuer Solutions business, has renewed its agreement with Wells Fargo (NYSE:WFC), the fourth largest bank in the United States.

TSYS will continue to provide a range of processing and support services for the bank’s commercial card portfolio. Notably, Wells Fargo has been utilizing TSYS’ payments processing platform since 1995.

Last month TSYS signed a multi-year payments pact with TD Bank Group including TD Bank, Canada and TD Bank, in the United States. TD is the sixth largest bank in North America, serving more than 26 million customers and ranks as one of the world’s leading online financial services firms with more than 14 million active digital customers.

In May, Truist Financial Corporation (NYSE:TFC) chose TSYS for the credit card processing services of its combined businesses including its consumer, commercial and small business credit card portfolios. The bank is expected to begin conversion-related activities in late 2021 to start using Total System’s issuer processing services in 2022.

These contract wins will aid the segment’s revenues, which accounted for 27% of the company’s consolidated revenues in the first six months of 2020. Starting mid-March, the segment experienced revenue declines as a result of lower transaction volumes, particularly related to the processing of commercial cards as a result of COVID-19. The segment, however, witnessed improvement in its financial results during May and June as the US state and local governments and those abroad began to ease restrictions.

TSYS was integrated into Global Payments last September when the former was acquired by the latter. The deal positioned Global Payments as a leading pure play payments technology company, providing innovative payments and software solutions to 3.5 million merchant locations and above 1,300 financial institutions across more than 100 countries throughout North America, Europe, the Asia Pacific and Latin America.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Through its Issuer Solutions segment, the company provides solutions that enable financial institutions and other financial service providers to manage their card portfolios, reduce technical complexity and overhead and offer a seamless experience for cardholders on a single platform. In addition, the segment provides flexible commercial payments and ePayables solutions that support business-to-business payment processes for businesses and governments.

Recently, Global Payments partnered with Aamzon Web Services (AWS), which will allow it to create a cloud-based processing platform for the card issuers. It will provide contactless payment options and improved digital banking experiences for large financial institutions. The AWS deal is likely to expand the company’s addressable market size by more than triple in the space of issuer solutions.

Another company that provides card processing services similar to TSYS’ Issuer Solutions is Fiserv Inc (NASDAQ:FISV). FISV.

Shares of Global Payments have lost 1.6% year to date against the industry’s increase of 9.2%.

Global Payments carries a Zacks Rank #3 (Hold), currently. Some better-ranked stocks in the same space are Envestnet (NYSE:ENV) Inc. ENV and Evertec (NYSE:EVTC) Inc. EVTC. While Envestnet sports a Zacks Rank #1 (Strong Buy), Evertec currently holds a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Earnings of Envestnet and Evertec beat estimates in the last reported quarter by 25.53% and 18.75%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Fiserv, Inc. (FISV): Free Stock Analysis Report

Envestnet, Inc (ENV): Free Stock Analysis Report

Global Payments Inc. (GPN): Free Stock Analysis Report

Evertec, Inc. (EVTC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.